Press releases | WebDisclosure

Basculer en Français

10964	Companies
239975	Keywords
168746	Articles
129114	Press releases

Home
Press releases

PRESS RELEASE

published on 09/11/2024 at 07:05, 2 years ago

Communiqué de presse : Dupixent : améliorations significatives du prurit et de l’urticaire confirmées par une étude de phase III chez des patients présentant une urticaire chronique spontanée
Dupixent : résultats positifs de l'étude de phase III confirmant l'efficacité du traitement de l'urticaire chronique spontanée non contrôlée. Nouvelle soumission réglementaire aux États-Unis

Traitement Dupixent Étude De Phase III Résultats Positifs Urticaire Chronique Spontanée
REGULATED PRESS RELEASE

published on 09/11/2024 at 07:00, 2 years ago

Strong interim results and new investments for TINC
TINC reports strong interim results with a net profit of €18.0 million and new investments totaling €50 million. The company plans to distribute a gross dividend of €0.58 per share

Net Profit Dividend Distribution TINC New Investments Interim Results
REGULATED PRESS RELEASE

published on 09/11/2024 at 07:00, 2 years ago

Strong interim results and new investments for TINC
Strong interim results with €18.0 million net profit and investments of €50 million for TINC. Plans to distribute €0.58 per share for current year

Net Profit Investments TINC Distribution Interim Results
REGULATED PRESS RELEASE

published on 09/11/2024 at 07:00, 2 years ago

Sterke tussentijdse resultaten en nieuwe investeringen voor TINC
Sterke tussentijdse resultaten en nieuwe investeringen voor TINC. TINC behaalt € 18,0 miljoen nettowinst en doet € 50 miljoen nieuwe investeringen in infrastructuur. Aandeelhouders mogen € 0,58 per aandeel verwachten

TINC Aandeelhouders Investeringen Tussentijdse Resultaten Nettowinst
PRESS RELEASE

published on 09/11/2024 at 07:00, 2 years ago

Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study
Dupixent achieves significant improvements in disease remission and symptoms in bullous pemphigoid study. Study met primary and key secondary endpoints with beneficial steroid-sparing effect

Dupixent Bullous Pemphigoid Disease Remission Symptoms Steroid-sparing Effect
PRESS RELEASE

published on 09/11/2024 at 06:30, 2 years ago

Bystronic announces a restructuring plan and moves closer to its customers through new organizational structure
Bystronic announces organizational restructuring plan to enhance customer proximity and reduce costs, ensures profitability over economic cycle

Profitability Cost Reduction Bystronic Customer Proximity Organizational Restructuring
PRESS RELEASE

published on 09/11/2024 at 06:30, 2 years ago

R&S Group published semi-annual report 2024
R&S Group Holding AG published its semi-annual report 2024, revealing significant growth in key figures. Join the conference call on 11 September 2024 for detailed insights

Financial Results Conference Call R&S Group Holding AG Key Figures Semi-annual Report 2024
PRESS RELEASE

published on 09/11/2024 at 05:45, 2 years ago

Presentation to Beaver Creek Precious Metals Summit
Barton Gold Holdings Limited to present at Beaver Creek Precious Metals Summit. Contact Managing Director & Company Secretary for details

Managing Director Presentation Barton Gold Holdings Beaver Creek Precious Metals Summit
PRESS RELEASE

published on 09/11/2024 at 01:40, 2 years ago

CORRECTION FROM SOURCE: Final Bell Holdings International Announces Update Regarding Rights Offering
Final Bell Holdings International Ltd. settles outstanding indebtedness of up to US$875,000 through Rights Offering. No discounts provided. Details on Rights Offering available on www.sedarplus.ca

Cannabis Final Bell Holdings Rights Offering Settlement Indebtedness
PRESS RELEASE

published on 09/11/2024 at 01:35, 2 years ago

Epique Realty Unveils Sisu: A Game-Changing Free Benefit for Agents
Epique Realty introduces Sisu to revolutionize commission processes and empower agents in real estate technology. The custom-built platform ensures transparency, efficiency, and agent-focused tools

Real Estate Technology Epique Realty Agent Empowerment Sisu Commission Processes

Accesswire

Published on 09/11/2026 at 04:00, 5 hours 11 minutes ago

Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 46 minutes ago

Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 17:46, 15 hours 25 minutes ago

Groete Access Road Nears Completion
Published on 09/10/2026 at 15:20, 17 hours 51 minutes ago

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 11 minutes ago

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 09:05, 5 minutes ago

ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 11 minutes ago

Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 09:00, 11 minutes ago

Picton Property Income Limited - Removal
Published on 09/11/2026 at 09:00, 11 minutes ago

Official List Notice
Published on 09/11/2026 at 09:00, 11 minutes ago

Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market

Les Echos

Published on 09/11/2026 at 07:00, 2 hours 11 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 11 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 2 hours 11 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 11 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 41 minutes ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE